![Clifford Roy Elcombe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Clifford Roy Elcombe
Corporate Officer/Principal bij University Of Dundee
Profiel
Clifford Roy Elcombe is the founder of CXR Biosciences Ltd., a company founded in 2001.
He held the title of Research Director from 2011 to 2016.
Currently, Dr. Elcombe is a Professor at the University of Dundee, a position he has held since 2012.
Previously, he worked as a Senior Scientist at Zeneca, Inc. Dr. Elcombe obtained his undergraduate and doctorate degrees from the University of Surrey.
Actieve functies van Clifford Roy Elcombe
Bedrijven | Functie | Begin |
---|---|---|
University Of Dundee | Corporate Officer/Principal | - |
Eerdere bekende functies van Clifford Roy Elcombe
Bedrijven | Functie | Einde |
---|---|---|
CXR Biosciences Ltd.
![]() CXR Biosciences Ltd. Pharmaceuticals: MajorHealth Technology CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom. | Oprichter | 25-08-2016 |
Zeneca, Inc. | Corporate Officer/Principal | - |
Opleiding van Clifford Roy Elcombe
University of Surrey | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
CXR Biosciences Ltd.
![]() CXR Biosciences Ltd. Pharmaceuticals: MajorHealth Technology CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom. | Health Technology |
Zeneca, Inc. |